{"id":4128,"date":"2024-09-27T08:58:25","date_gmt":"2024-09-27T08:58:25","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/"},"modified":"2026-01-22T15:01:26","modified_gmt":"2026-01-22T15:01:26","slug":"production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em","status":"publish","type":"poster","link":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/","title":{"rendered":"Cryo-EM for Structurally Enabled Therapeutic Antibody Development Against GPCRs"},"content":{"rendered":"<p>GPCR-targeting antibodies are increasingly important. Structurally aided maturation of GPCR-antibody interactions can enhance target engagement and reveal receptor conformational changes associated with antibody binding [1]. Cryo-electron microscopy (cryo-EM) is the preferred method for elucidating GPCR structures, including both agonist-bound active states and, increasingly, antagonist-bound inactive states [2]. Furthermore, cryo-EM provides an excellent tool for epitope mapping of GPCR-targeted antibodies. However, obtaining high-quality GPCR samples for antibody discovery and cryo-EM structure determination is challenging due to the inherent size, flexibility, and instability of GPCRs post-extraction from the membrane [3]. Effective strategies and critical decisions in construct design, expression, and purification are essential for producing high-quality samples to be used as immunogens and for successful imaging. We present a new cryo-EM structure of the 5-HT2A receptor, demonstrating scFv16 binding at its epitope and revealing a novel serotonin binding conformation.<\/p>\n<ol>\n<li>Peterson, S. M.; Hutchings, C. J.; Hu, C. F.; <em>et al<\/em>. Discovery and Design of G Protein-Coupled Receptor Targeting Antibodies. Expert Opin. Drug Discov. 2023, 18, 417\u2013428.<\/li>\n<li>Danev, R.; Belousoff, M.; Liang, Y.-L.; <em>et al<\/em>. Routine Sub-2.5 \u00c5 Cryo-EM Structure Determination of GPCRs. Nat. Commun. 2021, 12, 4333.<\/li>\n<li>Addis, P.; Bali, U.; Baron, F.; <em>et al<\/em>. Key Aspects of Modern GPCR Drug Discovery. SLAS Discov. 2023.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":2859,"template":"","category":[769,771,768,680,704,1],"class_list":["post-4128","poster","type-poster","status-publish","has-post-thumbnail","hentry","category-antibodies-and-biotherapeutics","category-cryo-em","category-membrane-proteins","category-protein-and-structure","category-structural-biology","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cryo-EM for Structurally Enabled Therapeutic Antibody Development Against GPCRs - Sygnature<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cryo-EM for Structurally Enabled Therapeutic Antibody Development Against GPCRs - Sygnature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-22T15:01:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Cryo-Em-for-structurally-enabled-therapeutic-antibody-development-against-GPCRs-e1744807451391.png\" \/>\n\t<meta property=\"og:image:width\" content=\"628\" \/>\n\t<meta property=\"og:image:height\" content=\"888\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\\\/\",\"name\":\"Cryo-EM for Structurally Enabled Therapeutic Antibody Development Against GPCRs - Sygnature\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Cryo-Em-for-structurally-enabled-therapeutic-antibody-development-against-GPCRs-e1744807451391.png\",\"datePublished\":\"2024-09-27T08:58:25+00:00\",\"dateModified\":\"2026-01-22T15:01:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Cryo-Em-for-structurally-enabled-therapeutic-antibody-development-against-GPCRs-e1744807451391.png\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Cryo-Em-for-structurally-enabled-therapeutic-antibody-development-against-GPCRs-e1744807451391.png\",\"width\":628,\"height\":888},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/poster\\\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cryo-EM for Structurally Enabled Therapeutic Antibody Development Against GPCRs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cryo-EM for Structurally Enabled Therapeutic Antibody Development Against GPCRs - Sygnature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/","og_locale":"fr_CA","og_type":"article","og_title":"Cryo-EM for Structurally Enabled Therapeutic Antibody Development Against GPCRs - Sygnature","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/","og_site_name":"Sygnature","article_modified_time":"2026-01-22T15:01:26+00:00","og_image":[{"width":628,"height":888,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Cryo-Em-for-structurally-enabled-therapeutic-antibody-development-against-GPCRs-e1744807451391.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/","name":"Cryo-EM for Structurally Enabled Therapeutic Antibody Development Against GPCRs - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Cryo-Em-for-structurally-enabled-therapeutic-antibody-development-against-GPCRs-e1744807451391.png","datePublished":"2024-09-27T08:58:25+00:00","dateModified":"2026-01-22T15:01:26+00:00","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Cryo-Em-for-structurally-enabled-therapeutic-antibody-development-against-GPCRs-e1744807451391.png","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Cryo-Em-for-structurally-enabled-therapeutic-antibody-development-against-GPCRs-e1744807451391.png","width":628,"height":888},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/poster\/production-and-structural-elucidation-of-5-ht2a-receptor-by-cryo-em\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"Cryo-EM for Structurally Enabled Therapeutic Antibody Development Against GPCRs"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/4128","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/poster"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/poster\/4128\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/2859"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=4128"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=4128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}